Liquidia Corporation

NasdaqCM:LQDA Stock Report

Market Cap: US$939.5m

Liquidia Past Earnings Performance

Past criteria checks 0/6

Liquidia's earnings have been declining at an average annual rate of -16.6%, while the Pharmaceuticals industry saw earnings growing at 1.2% annually. Revenues have been growing at an average rate of 27.9% per year.

Key information

-16.6%

Earnings growth rate

17.8%

EPS growth rate

Pharmaceuticals Industry Growth6.0%
Revenue growth rate27.9%
Return on equity-108.1%
Net Margin-765.4%
Last Earnings Update30 Sep 2024

Recent past performance updates

Recent updates

Is Liquidia (NASDAQ:LQDA) A Risky Investment?

Jul 18
Is Liquidia (NASDAQ:LQDA) A Risky Investment?

Broker Revenue Forecasts For Liquidia Corporation (NASDAQ:LQDA) Are Surging Higher

Jan 19
Broker Revenue Forecasts For Liquidia Corporation (NASDAQ:LQDA) Are Surging Higher

Liquidia Corporation's (NASDAQ:LQDA) P/S Still Appears To Be Reasonable

Dec 20
Liquidia Corporation's (NASDAQ:LQDA) P/S Still Appears To Be Reasonable

Is Liquidia (NASDAQ:LQDA) Using Debt In A Risky Way?

Aug 17
Is Liquidia (NASDAQ:LQDA) Using Debt In A Risky Way?

Need To Know: Analysts Are Much More Bullish On Liquidia Corporation (NASDAQ:LQDA) Revenues

Mar 18
Need To Know: Analysts Are Much More Bullish On Liquidia Corporation (NASDAQ:LQDA) Revenues

Is Liquidia (NASDAQ:LQDA) Using Too Much Debt?

Feb 06
Is Liquidia (NASDAQ:LQDA) Using Too Much Debt?

Revenue & Expenses Breakdown

How Liquidia makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

NasdaqCM:LQDA Revenue, expenses and earnings (USD Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
30 Sep 2416-1197843
30 Jun 2415-1126939
31 Mar 2416-1085847
31 Dec 2317-794543
30 Sep 2318-583435
30 Jun 2318-513132
31 Mar 2317-372819
31 Dec 2216-413319
30 Sep 2214-463519
30 Jun 2214-443419
31 Mar 2213-413118
31 Dec 2113-352420
30 Sep 2110-392220
30 Jun 217-472324
31 Mar 214-542427
31 Dec 201-602332
30 Sep 200-582235
30 Jun 200-571738
31 Mar 208-491441
31 Dec 198-481440
30 Sep 199-431041
30 Jun 199-391037
31 Mar 192-391032
31 Dec 183-53929
30 Sep 184-35927
30 Jun 186-45926
31 Mar 187-471026
31 Dec 177-291025
31 Dec 1613-16523

Quality Earnings: LQDA is currently unprofitable.

Growing Profit Margin: LQDA is currently unprofitable.


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: LQDA is unprofitable, and losses have increased over the past 5 years at a rate of 16.6% per year.

Accelerating Growth: Unable to compare LQDA's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: LQDA is unprofitable, making it difficult to compare its past year earnings growth to the Pharmaceuticals industry (54.6%).


Return on Equity

High ROE: LQDA has a negative Return on Equity (-108.1%), as it is currently unprofitable.


Return on Assets


Return on Capital Employed


Discover strong past performing companies

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/23 10:44
End of Day Share Price 2024/12/20 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Liquidia Corporation is covered by 15 analysts. 11 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Gregory HarrisonBofA Global Research
Jason Matthew GerberryBofA Global Research
Julian HarrisonBTIG